Completing data — refresh the page later to see the latest
1668-19-5CN(C)CC/C=C1\c2ccccc2COc2ccccc21ODQWQRRAPPTVAG-GZTJUZNOSA-NSee also: Doxepin (annotation moved to); Doxepin Hydrochloride (annotation moved to); (Z)-Doxepin (annotation moved to).
Pharmaceuticals -> Tricyclic Antidepressants (TCAs)
Pharmaceuticals -> Listed in ZINC15
Antidepressants -> Tricyclic antidepressants (TCA)
Pharmaceuticals
9
8.7
164.0 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: Antidepressants]
162.23 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P260, P263, P264, P270, P273, P280, P301+P316, P318, P321, P330, P391, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Uses(E)-Doxepin-d3, is a labeled analogue of (E)-Doxepin (D550005), used clinically to treat anxiety and depression. Doxepin is an antidepressant.
1668-19-5、3607-34-9DTXSID90859605CHEMBL860